These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 9160072)
1. Tongue protrusion dystonia: treatment with botulinum toxin. Charles PD; Davis TL; Shannon KM; Hook MA; Warner JS South Med J; 1997 May; 90(5):522-5. PubMed ID: 9160072 [TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin in Meige's syndrome: A video-based case series. Pandey S; Sharma S Neurol India; 2018; 66(1):71-76. PubMed ID: 29322963 [TBL] [Abstract][Full Text] [Related]
3. Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Schneider SA; Aggarwal A; Bhatt M; Dupont E; Tisch S; Limousin P; Lee P; Quinn N; Bhatia KP Neurology; 2006 Sep; 67(6):940-3. PubMed ID: 17000958 [TBL] [Abstract][Full Text] [Related]
4. Use of botulinum toxin in Meige's disease. Maurri S; Brogelli S; Alfieri G; Barontini F Riv Neurol; 1988; 58(6):245-8. PubMed ID: 3247565 [TBL] [Abstract][Full Text] [Related]
5. Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia. Bhattacharyya N; Tarsy D Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):389-92. PubMed ID: 11296046 [TBL] [Abstract][Full Text] [Related]
7. Clinical application of botulinum toxin type B in movement disorders and autonomic symptoms. Wan XH; Vuong KD; Jankovic J Chin Med Sci J; 2005 Mar; 20(1):44-7. PubMed ID: 15844312 [TBL] [Abstract][Full Text] [Related]
8. [Botulinum toxin A: experience in the treatment of 115 patients]. Andrade LA; Borges V; Ferraz HB; Azevedo-Silva SM Arq Neuropsiquiatr; 1997 Sep; 55(3B):553-7. PubMed ID: 9629404 [TBL] [Abstract][Full Text] [Related]
9. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin. Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762 [TBL] [Abstract][Full Text] [Related]
10. Effects of onabotulinum toxin type A injections in patients with Meige's syndrome. Duarte A; Coutinho L; Germiniani FMB; Teive HAG Arq Neuropsiquiatr; 2024 Apr; 82(4):1-7. PubMed ID: 38641339 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin as a treatment for tardive dyskinesia. van Harten PN; Hovestadt A Mov Disord; 2006 Aug; 21(8):1276-7. PubMed ID: 16671083 [TBL] [Abstract][Full Text] [Related]
12. Combination therapy for segmental craniocervical dystonia (Meige syndrome) with aripiprazole, trihexyphenidyl, and botulinum toxin: three cases reports. Saito T; Katayama T; Sawada J; Kano K; Asanome A; Takahashi K; Sato N; Hasebe N Neurol Sci; 2015 Feb; 36(2):243-5. PubMed ID: 25151364 [TBL] [Abstract][Full Text] [Related]
13. Clinical profile of various sub-types of writer's cramp. Das CP; Prabhakar S; Truong D Parkinsonism Relat Disord; 2007 Oct; 13(7):421-4. PubMed ID: 17400019 [TBL] [Abstract][Full Text] [Related]
14. [Meige's syndrome or segmental craniocervical dystonia: terminology, history and contemporary view]. Zalyalova ZA Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):133-136. PubMed ID: 26978507 [TBL] [Abstract][Full Text] [Related]
15. Refractory Open Jaw Oromandibular Tardive Dystonia with a Sensory Trick, Treated with Botulinum Toxin: A Case Report. Shalash AS; Abushouk AI; Elsherbeny MY; Elrassas H; Kamel T Neurol India; 2019; 67(4):1110-1111. PubMed ID: 31512647 [TBL] [Abstract][Full Text] [Related]
16. [Oromandibular dystonia and botulinum toxins]. Van Durme B; Loeb I; Van Reck J Acta Stomatol Belg; 1996 Mar; 93(1):37-41. PubMed ID: 9005716 [TBL] [Abstract][Full Text] [Related]
17. Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature. Hennings JM; Krause E; Bötzel K; Wetter TC Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1167-71. PubMed ID: 17936461 [TBL] [Abstract][Full Text] [Related]
18. Tardive dystonia, a case report. Veras AB; Rozenthal M; Nardi AE Braz J Psychiatry; 2006 Jun; 28(2):160-1. PubMed ID: 16810405 [No Abstract] [Full Text] [Related]
19. Complete remission of neuroleptic-induced Meige's syndrome by botulinum toxin treatment: a case report. Kurata K; Kuze S; Shibata R; Hatakeyama N; Masuda A; Ito Y; Kurachi M Jpn J Psychiatry Neurol; 1993 Mar; 47(1):115-9. PubMed ID: 8105127 [TBL] [Abstract][Full Text] [Related]
20. [Spasmodic dysphonia in course of Meige's syndrome--case report]. Zalesska-Krecicka M; Morawska-Kochman M; Wierzbicka E; Skrzypek A; Krecicki T Otolaryngol Pol; 2006; 60(5):779-81. PubMed ID: 17263254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]